<DOC>
	<DOCNO>NCT00413920</DOCNO>
	<brief_summary>This study investigate efficacy safety steroid avoidance regimen comparison steroid treatment combination initially high dose enteric-coated mycophenolate sodium ( EC-MPS ) cyclosporine microemulsion de novo renal transplant recipient . Patients randomly allocate receive either EC-MPS steroid combination EC-MPS . Patients treatment group receive monoclonal antibody induction therapy perioperative bolus steroid cyclosporine .</brief_summary>
	<brief_title>Efficacy Safety Enteric-coated Mycophenolate Sodium Cyclosporine Combination With Without Steroids , Adult Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Primary donor kidney transplant Panel reactive antibody ( PRA ) â‰¤ 20 % Multiorgan transplantation include dual kidney previous transplant organ different kidney Nonheart beat donor kidney noncompatible donor Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Steroids avoidance ,</keyword>
	<keyword>enteric-coated mycophenolate sodium ( EC-MPS ) ,</keyword>
	<keyword>de novo renal transplantation</keyword>
</DOC>